Data / Form D filings / TETRAPHASE PHARMACEUTICALS INC
TETRAPHASE PHARMACEUTICALS INC: Form D filings
TETRAPHASE PHARMACEUTICALS INC, a pharmaceuticals company in Watertown, MA, filed 3 Form D notices with the SEC between 2009 and 2020. The latest, on January 28, 2020, reports $10 million sold of a $10 million offering to 1 investor.
Find out what TETRAPHASE PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 480 ARSENAL WAY, Watertown, MA, 02472
- Phone
- (617) 715-3600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1373707
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 28, 2020 | New notice | $9,997,939 | $9,997,939 | $0 | 1 | Jan 24, 2020 | sec.gov |
| May 28, 2010 | New notice | $45,000,000 | $44,750,000 | $250,000 | 14 | May 14, 2010 | sec.gov |
| Sep 23, 2009 | New notice | $29,627,203 | $10,000,000 | $19,627,203 | 9 | Sep 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| L. Patrick Gage | Director | |
| Keith G. Maher | Director | |
| Guy G. Macdonald | Director | |
| Gerri G. Henwood | Director | |
| Larry Edwards | Executive Officer, Director | |
| Maria Stahl | Executive Officer | |
| Christopher Watt | Executive Officer | |
| Nancy J. Wysenski | Director | |
| Garen Patrick Bohlin | Director | |
| Steven Patrick Boyd | Director | |
| Jeffrey A. Chodakewitz | Director | |
| John G. Freund | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 27, 2020 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TETRAPHASE PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.